Dallas, TX, United States of America

Connie C Hsia

This inventor holds 3 USPTO granted patents. Top assignee: The University of Texas System. Active years: 1996-2022.


% Patents Active = 66.7

Average Co-Inventor Count = 2.8

ph-index = 1

Forward Citations = 15(Granted Patents)


Company Filing History:


Years Active: 1996-2022

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations by Connie C Hsia

Introduction

Connie C Hsia is an accomplished inventor based in Dallas, TX (US). She has made significant contributions to the field of drug delivery through her innovative research and development. With a total of 3 patents, her work focuses on utilizing nanoparticles for therapeutic applications.

Latest Patents

One of her latest patents involves the development of nanoparticles containing extracellular matrix for drug delivery. These nanoparticles are designed to deliver therapeutic proteins, nucleic acids, or drugs, and can be administered via inhalation or aerosol delivery. Additionally, she has developed methods for treating acute lung injury by administering α-Klotho protein or DNA to a subject. Another notable patent includes compositions comprising antisense-encoded erythropoietin receptor, which can be used to treat or prevent lung disorders.

Career Highlights

Connie C Hsia is affiliated with the University of Texas System, where she continues to advance her research in drug delivery systems. Her innovative approaches have garnered attention in the scientific community, contributing to the advancement of medical treatments.

Collaborations

Throughout her career, Connie has collaborated with notable colleagues such as Orson W Moe and Kytai Truong Nguyen. These partnerships have enhanced her research efforts and expanded the impact of her inventions.

Conclusion

Connie C Hsia's work exemplifies the intersection of innovation and healthcare, showcasing her dedication to improving drug delivery methods. Her contributions are paving the way for advancements in medical treatments and therapies.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…